These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 608858)

  • 1. Fluoxymesterone therapy in anemia of patients on maintenance hemodialysis: comparison between patients with kidneys and anephric patients.
    Acchiardo SR; Black WD
    J Dial; 1977; 1(4):357-66. PubMed ID: 608858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma erythropoietin levels in patients undergoing long-term hemodialysis.
    Raich PC; Korst DR
    Arch Pathol Lab Med; 1978 Feb; 102(2):73-5. PubMed ID: 579968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical effects of oral fluoxymesterone in patients with dialysis-controlled uremia.
    Lindholm DD; Fisher JW; Vieira JA; Dombeck DH; Bernal G; Lerthora J
    Trans Am Soc Artif Intern Organs; 1973; 19():475-83. PubMed ID: 4722764
    [No Abstract]   [Full Text] [Related]  

  • 4. Improvement of anemia with deferoxamine in hemodialysis patients with aluminum-induced bone disease.
    Tielemans C; Collart F; Wens R; Smeyers-Verbeeke J; van Hooff I; Dratwa M; Verbeelen D
    Clin Nephrol; 1985 Nov; 24(5):237-41. PubMed ID: 4075595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Testosterone therapy in hemodialysis patients.
    Ball JH; Lowrie EG; Hampers CL; Merrill JP
    Clin Nephrol; 1975; 4(3):91-8. PubMed ID: 1183099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of anemia in myeloproliferative disorders: a randomized study of fluoxymesterone v transfusions only.
    Brubaker LH; Brière J; Laszlo J; Kraut E; Landaw SA; Peterson P; Goldberg J; Donovan P
    Arch Intern Med; 1982 Aug; 142(8):1533-7. PubMed ID: 7103635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of androgens for anemia in patients on hemodialysis.
    Neff MS; Goldberg J; Slifkin RF; Eiser AR; Calamia V; Kaplan M; Baez A; Gupta S; Mattoo N
    N Engl J Med; 1981 Apr; 304(15):871-5. PubMed ID: 7010161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anemia in hemodialysis patients.
    Higgins MR; Grace M; Ulan RA; Silverberg DS; Bettcher KB; Dossetor JB
    Arch Intern Med; 1977 Feb; 137(2):172-6. PubMed ID: 836115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The intensity of hemodialysis and the response to erythropoietin in patients with end-stage renal disease.
    Ifudu O; Feldman J; Friedman EA
    N Engl J Med; 1996 Feb; 334(7):420-5. PubMed ID: 8552143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Red cells life span, splenic sequestration and transfusion requirements in chronic renal failure treated by hemodialysis. Effects of bilateral nephrectomy.
    Laurent C; Wittek M; Vereerstraeten P; Toussaint C; Naets JP
    Clin Nephrol; 1974; 2(1):35-40. PubMed ID: 4823492
    [No Abstract]   [Full Text] [Related]  

  • 11. Improvement in the anemia of chronic renal failure with fluoxymesterone.
    Eschbach JW; Adamson JW
    Ann Intern Med; 1973 Apr; 78(4):527-32. PubMed ID: 4632788
    [No Abstract]   [Full Text] [Related]  

  • 12. Lack of effect of vitamin E therapy on the anemia of patients receiving hemodialysis.
    Sinsakul V; Drake JR; Leavitt JN; Harrison BR; Fitch CD
    Am J Clin Nutr; 1984 Feb; 39(2):223-6. PubMed ID: 6364774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Response of uremic patients to nandrolone decanoate.
    Doane BD; Fried W; Schwartz F
    Arch Intern Med; 1975 Jul; 135(7):972-5. PubMed ID: 1156056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of total nephrectomy on hematopoiesis in patients undergoing chronic hemodialysis.
    Kominami N; Lowrie EG; Ianhez LE; Sakren A; Hampers CL; Merrill JP; Lange RD
    J Lab Clin Med; 1971 Oct; 78(4):524-32. PubMed ID: 5000358
    [No Abstract]   [Full Text] [Related]  

  • 15. Measurement of erythropoietin in anephric children. A report of the Southwest Pediatric Nephrology Study Group.
    Beckman BS; Brookins JW; Garcia MM; Fisher JW
    Pediatr Nephrol; 1989 Jan; 3(1):75-9. PubMed ID: 2702091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential role of parathyroid hormone as an inhibitor of erythropoiesis in the anemia of renal failure.
    McGonigle RJ; Wallin JD; Husserl F; Deftos LJ; Rice JC; O'Neill WJ; Fisher JW
    J Lab Clin Med; 1984 Dec; 104(6):1016-26. PubMed ID: 6501997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Erythropoietin in serum and urine in healthy persons and patients with chronic renal disease upon hypoxic stimulation and hypoxic stimulation after pretreatment with fluoxymesterone (author's transl)].
    Schulz E; Dickmans HA; Heesen D
    Klin Wochenschr; 1978 Oct; 56(20):1019-27. PubMed ID: 723183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of oral iron on the anaemia of patients on maintenance haemodialysis.
    Wallace MR
    N Z Med J; 1971 Sep; 74(471):167-70. PubMed ID: 5289829
    [No Abstract]   [Full Text] [Related]  

  • 19. Spontaneous increase in erythropoietin and hematocrit value associated with transient liver enzyme abnormalities in an anephric patient undergoing hemodialysis.
    Brown S; Caro J; Erslev AJ; Murray TG
    Am J Med; 1980 Feb; 68(2):280-4. PubMed ID: 7355898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant human erythropoietin resistance in hemodialysis. Effects of paired filtration dialysis.
    Carozzi S; Nasini MG; Santoni O; Tirotta A; Sanna A
    ASAIO J; 1997; 43(5):M535-8. PubMed ID: 9360100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.